News

December 30, 2019January 6, 2020

Seattle Genetics Seeks Tucatinib’s Approval by FDA for Advanced HER2-positive Breast Cancer

News

Seattle Genetics has submitted an application requesting U.S. Food and Drug Administration (FDA) approval for its investigational therapy tucatinib, in combination with trastuzumab and Xeloda (capecitabine), for treating people with locally ... Read more

December 19, 2019January 15, 2020

FDA Grants Breakthrough Therapy Status to Tucatinib for Advanced HER2-Positive Breast Cancer

News

The U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation to Seattle Genetics’ tucatinib, in combination with trastuzumab and Xeloda (capecitabine), for the treatment of patients with ... Read more

December 18, 2019January 15, 2020

TAVO Boosts Responses to Keytruda in Triple-negative Breast Cancer Patients, Interim Phase 2 Data Show

News

Treatment with TAVO (intratumoral IL-12) appears to increase the sensitivity of previously treated advanced triple-negative breast cancers (mTNBC) to the immune checkpoint inhibitor Keytruda (pembrolizumab), interim data from a ... Read more

December 17, 2019January 15, 2020

Dosing Complete in Phase 2 Trial Evaluating Lymfactin for BC Treatment-Associated Lymphedema

News

Herantis Pharma has completed patient dosing in its Phase 2 trial evaluating the investigational gene therapy Lymfactin for secondary lymphedema — a common complication of breast cancer treatment caused ... Read more

December 16, 2019

Breast Cancer Index Identifies Women Likely to Benefit From Extended Hormone Therapy, Latest Data Show

News

The Breast Cancer Index, a molecular test developed by Biotheranostics, successfully identified a group of women with hormone receptor (HR)-positive breast cancer who may benefit from long-term hormone therapy ... Read more

December 11, 2019December 11, 2019

FDA Approves FoundationOne CDx as Companion Diagnostic Test for Piqray Treatment

News

The U.S. Food and Drug Administration (FDA) has approved Foundation Medicine’s FoundationOne CDx as a companion diagnostic test for identifying advanced breast cancer patients with a PIK3CA mutation suitable ... Read more

December 9, 2019

HHS Grant to Advance Breast Cancer Screenings Based on Ultrasound

News

A U.S. Department of Health and Human Services grant will fund research at two universities into whether an ultrasound technology might be more effective than mammography at detecting breast cancer, ... Read more

December 6, 2019

CHMP Favors Kadcyla Approval in EU for Certain HER2-positive Early Breast Cancer Patients

News

The Committee for Medicinal Products for Human Use (CHMP), an arm of the European Medicines Agency, has recommended that Kadcyla (ado-trastuzumab emtansine) be approved as an adjuvant (post-surgery) treatment for certain ... Read more

December 4, 2019

Weight Loss Surgery May Lower Risk of Breast Cancer, Research Suggests

News

Weight loss surgery may reduce the risk of developing breast cancer in obese individuals, even among those with a genetic predisposition towards cancer, new research suggests. The research was ... Read more

November 15, 2019November 15, 2019

More Than $850M Raised for Inflammatory Breast Cancer Research

News

Susan G. Komen, the Inflammatory Breast Cancer (IBC) Research Foundation, and the Milburn Foundation have joined to raise more than $850,000 for research targeting innovative diagnostic tools and therapy ... Read more

Pin It on Pinterest